Point-of-Care Immunoassay for Detection of Bacterial Sinusitis

ENTvantage Dx800 enrolled

Overview

This study is conducted to evaluate the performance of a rapid, point-of-care in vitro diagnostic device (Sinu-Test®) for the qualitative detection of the three most common pathogens responsible for causing bacterial sinusitis.

Mucous specimens will be collected from patients displaying symptoms of acute bacterial sinusitis enrolled by primary care and/or otolaryngology clinics in the United States. Health care professionals not having endoscopy certification will collect specimens using the Entvantage sample collection device. Health care professionals with nasal endoscopy certification or specialty training will collect comparator specimens using an endoscope. Untrained operators with a range of education and training (primary care physician, otolaryngologist, physician assistant, nurse practitioner, registered nurse or other healthcare professional), will perform the Sinu-Test® lateral flow assay in an outpatient setting. Mucous samples will be tested for the presence of 3 bacterial pathogens responsible for sinusitis using the Sinu-Test® in the clinic and by a composite comparator method comprised of standard quantitative bacterial culture with identification (matrix-assisted laser desorption/ionization-Time of Flight (MALDI-TOF) mass spectrometry instrument) and semiquantitative real-time polymerase chain reaction (real-time PCR) of the residual culture sample and the Sinu-Test® residual swab performed by a central laboratory.

Study Type

OBSERVATIONAL

Enrollment

800

Conditions

Sinusitis Bacterial

Interventions

rapid in vitro diagnostic testDIAGNOSTIC_TEST

IVD for qualitative detection of 3 bacterial pathogens (Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae)

bacterial cultureDIAGNOSTIC_TEST

Quantitative bacterial culture assay with isolate identification by MALDI-TOF.

PCR assayDIAGNOSTIC_TEST

Semiquantitative real-time PCR assay

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Meets definition of acute sinusitis by Infectious Disease Society of America (2012) Exclusion Criteria: * Chronic sinusitis * Cystic fibrosis * Patients treated with antibiotics currently or within the previous 30 days. * Subjects with a prior history of sinus surgery will be excluded due to the modification of sinonasal anatomy. * Primary immunodeficiencies, as self-reported * Combined variable immunodeficiency * Immunodeficiency with reduced immunoglobulin G (IgG) and immunoglobulin A (IgA)-bearing cells * Kartagener Syndrome (ciliary dyskinesia) * Agammaglobulinemia * Sickle cell disease * Acquired immunodeficiencies, as self-reported * Chemotherapy * Radiation therapy * Transplantation * Asplenia * HIV * Poorly controlled Diabetes mellitus * Cognitive impairment resulting in the inability to provide informed consent. * Special groups, such as children under the age of 18, and men and women who are in prison will not participate in this study.

Locations (7)

Northern California Research

Sacramento, California, United States

Hillcrest Medical Research

DeLand, Florida, United States

ENT Allergy & Associates of South Florida

Port Saint Lucie, Florida, United States

Tandem Clinical Research

Marrero, Louisiana, United States

Outcomes

Primary Outcomes

Sensitivity (positive predictive agreement) and specificity (negative predictive agreement) of the diagnostic device

Assessment of the true positive and true negative rate of the point-of-care test device relative to the composite reference standard for each of the 3 bacterial microorganisms.

Time frame: Cumulation of one-time subject sample results obtained in 20-30 minutes for point-of-care test and 3-5 days for lab results

Secondary Outcomes

Positive predictive value (PPV) and negative predictive value (NPV)

Positive predictive value is the probability that subjects with a positive point-of-care test truly have the bacteria present. Negative predictive value is the probability that subjects with a negative point-of-care test truly do not have the bacteria present.

Time frame: Cumulation of one-time subject sample results obtained in 20-30 minutes for point-of-care test and 3-5 days for lab results

Positive likelihood ratio (LR+) and negative likelihood ratio (LR-)

LR+ is equivalent to the probability of a true positive result divided by the probability of a false positive result. LR- is equivalent to the probability of a false negative result divided by the probability of a true negative result.

Time frame: Cumulation of one-time subject sample results obtained in 20-30 minutes for point-of-care test and 3-5 days for lab results

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.